NDC 44567-501-01 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 44567-501
- Requested NDC
- 44567-501-01
- Package NDCs from labels
- 44567-501-01, 44567-501-10, 44567-501-02, 44567-501-90
- Manufacturer
- WG Critical Care, LLC
- Effective date
- 2024-03-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2024-03-29 | HUMAN PRESCRIPTION DRUG LABEL |
| Levetiracetam - WG Critical Care, LLC | WG Critical Care, LLC | 2023-10-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 44567-501-01 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 6 | |
| 44567-501-10 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 6 | |
| 44567-501-02 | Levetiracetam | 100 mL in 1 BAG | INJECTION | 100 | 3 | |
| 44567-501-90 | Levetiracetam | 10 in 1 CARTON | INJECTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 44567-501 | LEVETIRACETAM INJECTION [WG CRITICAL CARE, LLC] | 5 | Current NDC, Legacy NDC, 2 package rows | 20240601_62f3d1c8-ca5b-4760-9fc9-41e4fb4cc926.zip |
| 44567-501 | LEVETIRACETAM INJECTION [WG CRITICAL CARE, LLC] | 3 | Current NDC, Legacy NDC, 2 package rows | 20240113_5e5b0ed3-b104-45a7-bb3e-ee56febb46e8.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 44567-501-01 | ML - Milliliter | 44567-501 | 9e2d0692-78d1-449a-9b18-1555c0c12a1b | 1 | 2022-07-06 |
| 44567-501-02 | ML - Milliliter | 44567-501 | 99ebf4bb-00a7-4827-b7a9-becb303cd0f8 | 1 | 2023-06-06 |
| 44567-501-10 | ML - Milliliter | 44567-501 | cff2ee94-7849-4182-85fb-4dd98195753d | 1 | 2022-06-06 |
| 44567-501-90 | ML - Milliliter | 44567-501 | 080c3ef7-7acd-460a-a666-737f289d63c7 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM | Mylan Pharmaceuticals Inc. | 0a987d59-560f-4650-96ec-31aec81953b5 | 2025-04-12 | Warnings, Adverse reactions | 44YRR34555 |
| Nat Mur 6X | SODIUM CHLORIDE | Hyland's Inc. | dcf0e2ac-3b69-3ae4-e053-2a95a90aaf41 | 2025-04-10 | Warnings | 451W47IQ8X |
| LEVETIRACETAM | LEVETIRACETAM | QUAGEN PHARMACEUTICALS LLC | 1d67cb3c-1173-4dce-a79b-a3c36934ab2e | 2025-04-03 | Warnings, Adverse reactions | 44YRR34555 |
| Eye Wash | WATER | CMC Group Inc. | 6158a1f5-a6bc-4a3e-9d1d-0a310d9dc561 | 2025-04-02 | Warnings | 059QF0KO0R |
| Kidneyforce-HP | ARNICA MONTANA, AURUM METALLICUM, CACTUS GRANDIFLORUS, CALCAREA CARBONICA, NATRUM MURIATICUM, NUX VOMICA, PHOSPHORUS, SOLIDAGO VIRGAUREA | BioActive Nutritional, Inc. | 0c0f0c0c-10c2-47eb-aad6-bbffb6e16799 | 2025-04-02 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | Hikma Pharmaceuticals USA Inc. | 8d767545-1eb9-45a5-bd16-e8a66e628fea | 2025-04-01 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Solco Healthcare US, LLC | cfe618ae-f7de-43d8-a754-3ce0a08c48ee | 2025-03-26 | Warnings, Adverse reactions | 44YRR34555 |
| Sodium Chloride | SODIUM CHLORIDE TABLET | Belleview Bioscience LLC | 31195e8f-d4de-9e37-e063-6294a90a4156 | 2025-03-24 | Warnings | 451W47IQ8X |
| Pituitary Liquescence | CAULOPHYLLUM THALICTROIDES, HYPOPHYSIS SUIS, HYPOTHALAMUS SUIS, PINEAL GLAND (SUIS), CIMICIFUGA RACEMOSA, NATRUM MURIATICUM, CINCHONA OFFICINALIS, ADRENOCORTICOTROPHIN | Nutritional Specialties, Inc. | 292ca967-abe8-4ae1-b2fe-942531a1e14a | 2025-03-20 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | Preferred Pharmaceuticals Inc. | 8c16bc7b-672c-420a-a457-350060533375 | 2025-03-20 | Warnings, Adverse reactions | 44YRR34555 |
| Anxiety HP | ACONITUM NAPELLUS, ARGENTUM NITRICUM, ARSENICUM ALBUM, CALCAREA CARBONICA, IGNATIA AMARA, KALI CARBONICUM, LACHESIS MUTUS, NATRUM MURIATICUM, PHOSPHORUS, PULSATILLA (PRATENSIS), STAPHYSAGRIA, STRAMONIUM | Energique, Inc. | 191393fa-5f36-43c0-a183-09258eef9bda | 2025-03-20 | Warnings | 451W47IQ8X |
| HYDRA NEB | SODIUM CHLORIDE | Venture Healthcare Ltd | 30b184bf-2451-d96b-e063-6294a90a43c7 | 2025-03-19 | Warnings | 451W47IQ8X |
| HYDRA NEB | SODIUM CHLORIDE | Laboratoire Unither | 30b244c0-84bb-a0a0-e063-6394a90a9dee | 2025-03-19 | Warnings | 451W47IQ8X |
| Levetiracetam | LEVETIRACETAM | A-S Medication Solutions | c82313cb-744f-45ef-b74c-1bdd055b2193 | 2025-03-18 | Warnings, Adverse reactions | 44YRR34555 |
| Psora Miasm | EGGSHELL MEMBRANE, WHEY PROTEIN, CALCAREA CARBONICA, LYCOPODIUM CLAVATUM, SULPHUR, ARSENICUM ALBUM, CROTON TIGLIUM, GRAPHITES, HYDROCOTYLE ASIATICA, NATRUM MURIATICUM | Energique, Inc. | 6a12aa49-35fc-41f4-bec8-6f9a20a97caa | 2025-03-13 | Warnings | 451W47IQ8X |
| Bestmade Natural Products BM253 | CALC FLUOR, CALC PHOS, FERR PHOS, KALI MUR, KALI PHOS, MAG PHOS, NAT MUR | Bestmade Natural Products | 2fa9913f-0593-f77b-e063-6394a90ab6b2 | 2025-03-06 | Warnings | 451W47IQ8X |
| Bestmade Natural Products BM254 | APIS MEL, BRYONIA, GELSEMIUM, NAT MUR, PULSATILLA | Bestmade Natural Products | 2fa9bb2c-848b-06ef-e063-6394a90ad0f0 | 2025-03-06 | Warnings | 451W47IQ8X |
| Bestmade Natural Products BM244 | CALC CARB, CALC PHOS, CARBO VEG, NAT MUR, PHYSOSTIGMA, RUTA GRAV. | Bestmade Natural Products | 2f853410-e831-90ce-e063-6394a90a26b1 | 2025-03-04 | Warnings | 451W47IQ8X |
| Bestmade Natural Products BM214 | CARBO VEG, FERRUM PHOS, SILICA, KALI CARB, CALC PHOS, NAT MUR | Bestmade Natural Products | 2f6e08d8-a6f9-c049-e063-6394a90a6df1 | 2025-03-03 | Warnings | 451W47IQ8X |
| LEVETIRACETAM | LEVETIRACETAM | Kesin Pharma Corporation | 30a4626d-74f3-6385-e063-6394a90a2950 | 2025-03-01 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.